AI assistant
CANN GROUP LIMITED — Capital/Financing Update 2021
Sep 29, 2021
64603_rns_2021-09-29_ea12e73b-a233-4e3e-ab1d-48a7a821fc6b.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [121 x 47] intentionally omitted <==
ASX ANNOUNCEMENT
30 September 2021
Share purchase plan offer closing date extended
30 September 2021 – Cann Group Limited (ASX: CAN) ( Cann or the Company ) refers to the Share Purchase Plan ( SPP ) announced on 7 September 2021 and advises that the closing date for applications has been extended by ten days, to 5.00pm (Melbourne time) on Friday, 15 October 2021.
The Company has been made aware that many of its shareholders have experienced difficulties in either receiving materials due to postal delays, or accessing the SPP online platform.
The extension has been granted to ensure that all eligible shareholders have an opportunity to participate in the SPP.
Shareholders who have already applied for shares under the SPP do not need to take any further action unless they wish to apply for additional shares, up to a maximum application amount of $30,000, as referred to in the SPP offer documents released on 13 September 2021.
All other terms of the SPP remain the same.
An updated SPP timetable is below:
| er terms of the SPP remain the same.ated SPP timetable is below: | |
|---|---|
| Event | Date |
| SPP Offer closes | 5:00pm (Melbourne time) Friday, 15October 2021 |
| Completion announcement date(and notice of scale backs, if any) | Thursday, 21 October 2021 |
| Allotment Date | Friday, 22 October 2021 |
| Dispatch Holding Statements | Monday, 25 October 2021 |
The above timetable is indicative only and subject to change at the discretion of the Company.
The Company welcomes the support it has received from shareholders for the SPP to date and looks forward to completing this important capital raise.
Authorised for release by the Board of Directors of Cann Group Limited.
Cann Group Limited ACN 603 949 739 4 Research Avenue, Bundoora, VIC 3083 Australia Ph: +61 3 9095 7088
==> picture [78 x 31] intentionally omitted <==
For all media enquiries please contact:
Matthew Wright NWR Communications +61 451 896 420 [email protected]
For all other information please contact:
Peter Crock Clive Fanning CEO Head of Investor Relations Cann Group Limited Cann Group Limited +61 3 9095 7088 +61 3 9095 7088 [email protected] [email protected]
About Cann Group
Cann Group Limited (ABN 25 603 949 739) is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved overseas export markets. Cann also owns Satipharm, a Europe-based business exclusively licensed to manufacture, develop and market the proprietary Gelpell delivery system for cannabinoids. Cann has established research and cultivation facilities in Melbourne and is developing a state-of-the-art cultivation and manufacturing facility near Mildura, Victoria. Cann Group has established a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. The Company is commercialising a range of imported and locally sourced and manufactured medicinal cannabis products.
Learn more at: www.canngrouplimited.com | www.satipharm.com
2